Provided by Tiger Trade Technology Pte. Ltd.

Redhill Biopharma

1.03
+0.370256.01%
Volume:97.39M
Turnover:118.69M
Market Cap:6.27M
PE:-7.59
High:1.60
Open:1.36
Low:1.01
Close:0.6610
52wk High:2.79
52wk Low:0.5700
Shares:6.08M
Float Shares:5.02M
Volume Ratio:5,310.73
T/O Rate:1940.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1358
EPS(LYR):-0.1358
ROE:-1708.61%
ROA:-22.79%
PB:1.47
PE(LYR):-7.59

Loading ...

NASDAQ Trade Halt Volatility Trading Pause at 09:36 Am

Reuters
·
Yesterday

RedHill Biopharma Sells Talicia Stake to Apotex for $18 Million Upfront

Reuters
·
Yesterday

Press Release: RedHill Divests Talicia(R) to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities

Dow Jones
·
Yesterday

NASDAQ Trade Halt Halt News Pending at 06:57 Am

Reuters
·
Yesterday

RedHill Biopharma Releases Corporate Presentation Outlining Talicia Commercialization, Late-stage Pipeline Progress

Reuters
·
Aug 03

Redhill Biopharma Delays Annual Shareholder Meeting to Aug. 6 to Add Proposal to Proxy Materials

Reuters
·
Jul 01

Redhill Biopharma Ups Maximum Size of H.C. Wainwright-led ATM ADS Offering

Reuters
·
Jun 29

RedHill Biopharma Closes Private Placement

MT Newswires Live
·
Jun 23

RedHill Biopharma prices $6 million private placement of ADSs at $0.7 each

Reuters
·
Jun 23

RedHill Biopharma prices $6 million private placement at $0.70 per ADS

Reuters
·
Jun 18

Press Release: RedHill Biopharma Announces Up To $19.4 Million Private Placement

Dow Jones
·
Jun 18

RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside

TIPRANKS
·
Jun 16

RedHill Biopharma posts corporate presentation on Talicia commercialization and GI-focused pipeline

Reuters
·
Jun 15

RedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst

TIPRANKS
·
Jun 10

RedHill Biopharma's Opaganib Gains FDA Rare Pediatric Disease Status for Neuroblastoma

MT Newswires Live
·
Jun 09

RedHill says FDA grants opaganib rare pediatric disease designation for neuroblastoma

Reuters
·
Jun 09

RedHill Biopharma launches enforcement of $11M judgment against Kukbo

TIPRANKS
·
Jun 08

Redhill Biopharma Advances Opaganib Options For Ebola Virus Disease Outbreak

Reuters
·
Jun 04

RedHill Biopharma discusses adding opaganib to WHO Ebola trial platform

Reuters
·
Jun 04

RedHill Biopharma - Actively Discussing Potential Collaborations For Advancement Of Its Investigational Oral Drug, Opaganib

Reuters
·
Jun 02